RKSG Among Growth ETFs
End-of-day Nov 19, 2026 · 92 Growth ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | 0.0% | −3.3% | −4.9% | −3.7% | — | — | — | — | — | +10.5% |
| Peer average | −2.1% | −6.1% | −10.2% | −10.3% | −2.4% | +2.0% | +56.9% | +39.6% | +330.7% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$90 of every $1,000 in RKSG is Apple
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | AAPLApple | Technology | 9.03% | $903.14 | 710 | $250K |
| 2 | NVDANvidia | Technology | 7.41% | $740.97 | 1,360 | $205K |
| 3 | MSFTMicrosoft | Technology | 5.22% | $521.82 | 285 | $145K |
| 4 | GOOGLAlphabet | Communication Services | 4.94% | $494.39 | 485 | $137K |
| 5 | LLYEli Lilly | Healthcare | 4.24% | $424.19 | 85 | $118K |
| 6 | AMZNAmazon | Consumer Cyclical | 3.38% | $338.21 | 350 | $94K |
| 7 | AVGOBroadcom | Technology | 2.24% | $223.62 | 175 | $62K |
| 8 | METAMETA Platforms | Communication Services | 2.22% | $222.46 | 100 | $62K |
| 9 | JNJJohnson & Johnson | Healthcare | 2.02% | $201.76 | 205 | $56K |
| 10 | MRKMerck | Healthcare | 1.86% | $186.47 | 375 | $52K |
| 11 | ABBVAbbVie | Healthcare | 1.86% | $185.80 | 180 | $51K |
| 12 | KOCoca-Cola /The | Consumer Defensive | 1.65% | $164.62 | 465 | $46K |
| 13 | LMTLockheed Martin | Industrials | 1.57% | $156.51 | 75 | $43K |
| 14 | REGNRegeneron Pharmaceuticals | Healthcare | 1.54% | $153.56 | 45 | $43K |
| 15 | ALLAllstate /The | Financial Services | 1.49% | $149.13 | 155 | $41K |
Not enough history yet: RKSG needs a year of prices.
RKSG does not pay a distribution.
of the $539B in 113 Growth ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | AAPL | Apple | 9.03% |
| 2 | NVDA | Nvidia | 7.41% |
| 3 | MSFT | Microsoft | 5.22% |
| 4 | GOOGL | Alphabet | 4.94% |
| 5 | LLY | Eli Lilly & | 4.24% |
| 6 | AMZN | Amazon | 3.38% |
| 7 | AVGO | Broadcom | 2.24% |
| 8 | META | META Platforms | 2.22% |
| 9 | JNJ | Johnson & Johnson | 2.02% |
| 10 | MRK | Merck & | 1.86% |
Estimated yearly cost excludes trading costs and assumes constant assets.
No payouts on record: […]